Compare LFMD & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFMD | SAR |
|---|---|---|
| Founded | 1994 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.1M | 200.7M |
| IPO Year | 2012 | 2006 |
| Metric | LFMD | SAR |
|---|---|---|
| Price | $2.20 | $11.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 7 |
| Target Price | $8.13 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 874.6K | 138.7K |
| Earning Date | 11-12-2026 | 10-06-2026 |
| Dividend Yield | N/A | ★ 25.75% |
| EPS Growth | ★ 141.67 | 14.36 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,468,578.00 | N/A |
| Revenue This Year | $5.37 | $0.78 |
| Revenue Next Year | $17.75 | $6.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 49.79 | N/A |
| 52 Week Low | $1.60 | $11.51 |
| 52 Week High | $5.38 | $24.07 |
| Indicator | LFMD | SAR |
|---|---|---|
| Relative Strength Index (RSI) | 47.88 | 21.21 |
| Support Level | $2.06 | N/A |
| Resistance Level | $2.49 | $14.27 |
| Average True Range (ATR) | 0.22 | 0.51 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 66.85 | 2.83 |
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.